Inclusion Criteria:

- Patients with known or suspected metachronous liver metastases secondary to
colorectal cancer who are scheduled for further contrast-enhanced tomographic imaging

Exclusion Criteria:

- Patients (men or women) under 18 years of age

- Patients who have received any contrast material within 24 hours before injection of
study drug, or who are scheduled to receive any contrast material within 24 hours
after injection

- Patients not eligible to contrast media (CM) injection according to product labeling

- Women who are pregnant, lactating or who are of childbearing potential and have not
had a negative urine pregnancy test at baseline visit(s)

- Patients scheduled for liver-specific MRI other than Primovist-enhanced MRI, i.e.
Multihance-, Teslascan- or SPIO-enhanced MRI

- Patients who are clinically unstable and whose clinical course is unpredictable (e.g.
due to previous surgery, acute myocardial infarction)

- Patients with known anaphylactoid or anaphylactic reaction to any contrast media or
hypersensitivity to any allergen including drugs

- Patients with a contraindication for MRI or CT.

- Patients with severe renal impairment (eGFR < 30ml/min/1.73m2) or patients on
dialysis